4.6 Article

24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma

期刊

OPHTHALMOLOGY
卷 124, 期 10, 页码 1449-1456

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ophtha.2017.04.021

关键词

-

资金

  1. Carl Zeiss Meditec, Inc
  2. Heidelberg Engineering
  3. Topcon Inc.
  4. Heidelberg Engineering GmbH
  5. Alcon Laboratories Inc
  6. Carl Zeiss Meditec Inc
  7. Pfizer Inc
  8. Allergan Inc
  9. Reicherts Inc.
  10. Optovue Inc
  11. Topcon Medical Systems
  12. Quark
  13. Genentech
  14. National Eye Institute [U10EY14267, EY08208, EY11008, EY019869, EY13959, EY02115, EY025253]
  15. Eyesight Foundation of Alabama
  16. Merck Inc
  17. Santen Inc
  18. Research to Prevent Blindness, New York
  19. New York (Department of Ophthalmology, Columbia University Medical Center)
  20. New York (Department of Ophthalmology, University of California San Diego)
  21. Edith C. Blum Foundation, New York, New York

向作者/读者索取更多资源

Purpose: To investigate the prevalence of visual field defects in glaucomatous eyes, glaucoma suspects, and ocular hypertensives with 24-2 and 10-2 visual fields. Design: Prospective, cross-sectional study. Participants: Patients with or suspected glaucoma tested with 24-2 and 10-2. Patients were classified into 3 groups on the basis of the presence of glaucomatous optic neuropathy (GON) and 24-2 visual field abnormalities: early glaucoma (GON and abnormal visual field, mean deviation > - 6 decibels [dB]), glaucoma suspects (GON and normal visual field), and ocular hypertensives (normal disc, normal visual field, and intraocular pressure > 22 mmHg). For the classification of visual field abnormalities, 24-2 and 10-2 tests performed on the same visit were analyzed. Main Outcome Measures: Comparison of the prevalence of abnormal 24-2 versus 10-2 visual field results based on cluster criteria in each diagnostic group. Results: A total of 775 eyes (497 patients) were evaluated. A total of 364 eyes had early glaucoma, 303 eyes were glaucoma suspects, and 108 eyes were ocular hypertensives. In the glaucoma group, 16 of the 26 eyes (61.5%) classified as normal based on cluster criteria on 24-2 tests were classified as abnormal on 10-2 visual fields. In eyes with suspected glaucoma, 79 of the 200 eyes (39.5%) classified as normal on the 24-2 test were classified as abnormal on 10-2 visual fields. In ocular hypertensive eyes, 28 of the 79 eyes (35.4%) classified as normal on the 24-2 were classified as abnormal on the 10-2. Patients of African descent were more likely to have an abnormal 10-2 result (67.3 vs. 56.8%, P = 0.009). Conclusions: Central visual field damage seen on the 10-2 test is often missed with the 24-2 strategy in all groups. This finding has implications for the diagnosis of glaucoma and classification of severity. (C) 2017 by the American Academy of Ophthalmology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据